Hennion & Walsh Asset Management’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.09M | Sell |
|
|||||
|
2025
Q2 | $848K | Buy |
|
|||||
|
2025
Q1 | $966K | Buy |
|
|||||
|
2024
Q4 | $949K | Buy |
|
|||||
|
2024
Q3 | $364K | Sell |
|
|||||
|
2024
Q2 | $535K | Sell |
|
|||||
|
2024
Q1 | $827K | Buy |
|
|||||
|
2023
Q4 | $736K | Sell |
|
|||||
|
2023
Q3 | $475K | Buy |
|
|||||
|
2023
Q2 | $1.05M | Buy |
|
|||||
|
2023
Q1 | $748K | Buy |
|
|||||
|
2022
Q4 | $487K | Sell |
|
|||||
|
2022
Q3 | $3.94M | Sell |
|
|||||
|
2022
Q2 | $2.76M | Sell |
|
|||||
|
2022
Q1 | $6.06M | Sell |
|
|||||
|
2021
Q4 | $6.47M | Sell |
|
|||||
|
2021
Q3 | $6M | Sell |
|
|||||
|
2021
Q2 | $11.9M | Buy |
|
|||||
|
2021
Q1 | $7.47M | Buy |
|